Open Access Highly Accessed Pre-publication history

Maintenance bevacizumab beyond first-line paclitaxel plus bevacizumab in patients with Her2-negative hormone receptor-positive metastatic breast cancer: efficacy in combination with hormonal therapy

Alessandra Fabi*, Michelangelo Russillo, Gianluigi Ferretti, Giulio Metro, Cecilia Nisticò, Paola Papaldo, Ferdinando De Vita, Giuliana D’Auria, Antonello Vidiri, Diana Giannarelli and Francesco Cognetti

BMC Cancer 2012, 12:482  doi:10.1186/1471-2407-12-482

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 27 Dec 2011
Reviewer's Report Antonio Frassoldati 12 Jan 2012
Reviewer's Report Sara Hurvitz 11 Mar 2012
Resubmission - Version 2 Manuscript Author's comment 11 Apr 2012
Reviewer's Report Antonio Frassoldati 02 Jul 2012
Reviewer's Report Sara Hurvitz 03 Jul 2012
Resubmission - Version 3 Manuscript Author's comment 06 Aug 2012
Reviewer's Report Sara Hurvitz 02 Sep 2012
Editorial acceptance 22 Sep 2012
Published 19 Oct 2012